Urinary incontinence in US adults aged ≥55 years with type 2 diabetes and indications for SGLT2is: NHANES 2013–2020
Objective Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended as first-line cardiorenal protective therapy in type 2 diabetes. Because SGLT2is cause glycosuria and increase urine volume, they may exacerbate incontinence symptoms among patients with pre-existing urinary incontinence....
Saved in:
Main Authors: | Sei J Lee, Eva Raphael, Kathryn E Callahan, Kasia J Lipska, Alexandra K Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2025-07-01
|
Series: | BMJ Open Diabetes Research & Care |
Online Access: | https://drc.bmj.com/content/13/4/e004929.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gestational and Type 2 Diabetes in Relation to Urinary Incontinence in Black Women in the U.S.
by: Yvette C. Cozier, et al.
Published: (2025-04-01) -
RECURRENT URINARY INCONTINENCE
by: G. R. Kasyan, et al.
Published: (2014-09-01) -
The Concept and Pathophysiology of Urinary Incontinence
by: Hemaly, Abdel Karim M. El, et al.
Published: (2012) -
Refractory Stress Urinary Incontinence
by: Lenherr, Sara M., et al.
Published: (2012) -
Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)